| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |